Effect of COX-2 inhibitors and non-steroidal anti-inflammatory drugs on a mouse fracture model

Injury

Volumn 37, Issue 9, 2006, Pages 827-837

  Mullis, Brian H ^a   Copland, Spencer T ^b   Weinhold, Paul S ^c   Miclau, Theodore ^d   Lester, Gayle E ^c   Bos, Gary D ^e  

^a FLORIDA ORTHOPAEDIC INSTITUTE   (United States)

^b CAROLINAS MEDICAL CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e OHIO STATE UNIVERSITY   (United States)

Author keywords

Animal; Celecoxib; COX 2; Fracture; Ibuprofen; Indomethacin; Ketorolac; Model; NSAIDs; Rofecoxib

Indexed keywords

CELECOXIB; CHONDROITIN; COLLAGEN TYPE 10; COLLAGEN TYPE 2; CYCLOOXYGENASE 2 INHIBITOR; DERMATAN SULFATE; DNA; HYDROXYPROLINE; IBUPROFEN; INDOMETACIN; KETOROLAC; NONSTEROID ANTIINFLAMMATORY AGENT; OSTEOCALCIN; PLACEBO; PROTEIN; ROFECOXIB;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOMECHANICS; CHEMICAL ANALYSIS; CONTROLLED STUDY; DISEASE MODEL; DNA CONTENT; DRUG EFFECT; ENERGY ABSORPTION; FRACTURE; FRACTURE HEALING; HISTOLOGY; IN SITU HYBRIDIZATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RIGIDITY; STAINING; TIBIA FRACTURE;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOMECHANICS; CYCLOOXYGENASE 2 INHIBITORS; FRACTURE HEALING; FRACTURES, BONE; MALE; MICE; MICE, INBRED C57BL; RANDOM ALLOCATION;

EID: 33747329851     PISSN: 00201383     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.injury.2005.12.018     Document Type: Article

References (60)

1. Allen H.L., Wase A., and Bear W.T. Indomethacin and aspirin: effect of non-steroidal anti-inflammatory agents on the rate of fracture repair in the rat. Acta Orthop Scand 51 4 (1980) 595-600
2. Altman R.D., Latta L.L., Keer R., et al. Effect of non-steroidal anti-inflammatory drugs on fracture healing: a laboratory study in rats. J Orthop Trauma 9 5 (1995) 392-400
3. Bo J., Sudmann E., and Marton P.F. Effect of indomethacin on fracture healing in rats. Acta Orthop Scand 47 6 (1976) 588-599
4. Bonnarens F., and Einhorn T.A. Production of a standard closed fracture in laboratory animal bone. J Orthop Res 2 1 (1984) 97-101
5. Bremer M. In: Mullis B. (Ed). Celecoxib dosage in the mouse (2000), Monsanto
6. Brown K.M., Saunders M.M., Kirsch T., et al. Effect of COX-2-specific inhibition on fracture-healing in the rat femur. J Bone Joint Surg 86-A 1 (2004) 116-123
7. Burd T.A., Hughes M.S., and Anglen J.O. Heterotopic ossification prophylaxis with indomethacin increases the risk of long-bone non-union. J Bone Joint Surg 85-B 5 (2003) 700-705
8. Butcher C.K., and Marsh D.R. Non-steroidal anti-inflammatory. Injury 27 (1996) 375
9. Cappell M.S., and Schein J.R. Diagnosis and treatment of non-steroidal anti-inflammatory drug-associated upper gastrointestinal toxicity. Gastroenterol Clin North Am 29 1 (2000) 97-124
10. Christian C. General principles of fracture treatment. In: Canale S.T. (Ed). Campbell's operative orthopaedics (1998), St. Louis, Mosby 1993-2041
11. Coles C., Barei D., Bellabarba C., et al. In: Orthopaedic Trauma Association (Ed). Risk factors for stiffness following operative fixation of supracondylar/intercondylar fractures of the distal humerus (2004), Fort Lauderdale, FL 302-303
12. Dahners L., and Mullis B. Effects of non-steroidal anti-inflammatory drugs on bone formation and soft-tissue healing. J Am Acad Orthop Surg 12 3 (2004) 139-142
13. Dimar J.R., Ante W.A., Zhang Y., and Glassman S.D. The effects of non-steroidal anti-inflammatory drugs on posterior spinal fusions in the rat. Spine 21 16 (1996) 1870-1876
14. Einhorn T.A. COX-2: where are we in 2003? The role of cyclooxygenase-2 in bone repair. Arthritis Res Ther 5 1 (2003) 5-7
15. Elves M.W., Bayley I., and Roylance P.J. The effect of indomethacin upon experimental fractures in the rat. Acta Orthop Scand 53 1 (1982) 35-41
16. Endo K., et al. Cyclooxygenase-2 inhibitor inhibits the fracture healing. J Physiol Anthropol Appl Human Sci 21 5 (2002) 235-238
17. Forwood M.R. Inducible cyclooxygenase (COX-2) mediates the induction of bone formation by mechanical loading in vivo. J Bone Miner Res 11 11 (1996) 1688-1693
18. Fu J.Y., Masferrer J.L., Seibert K., et al. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem 265 28 (1990) 16737-16740
19. Gerstenfeld L., Thiede M., Seibert K., et al. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J Orthop Res 21 4 (2003) 670-675
20. Gerstenfeld L, Thiede M, Seibert K, et al. Differential inhibition of fracture healing by non-specific and cyclooxygenase-2 (COX-2) specific non-steroidal anti-inflammatory drugs. Proceedings of the 48th annual meeting of the orthopaedic research society, paper no. 0239. Dallas, TX; 2002.
21. Giannoudis P.V., MacDonald D.A., Matthews S.J., et al. Non-union of the femoral diaphysis. The influence of reaming and non-steroidal anti-inflammatory drugs. J Bone Joint Surg Br 82 5 (2000) 655-658
22. Granados-Soto V., Lopez-Munoz F.J., Hong E., and Flores-Murrieta F.J. Relationship between pharmacokinetics and the analgesic effect of ketorolac in the rat. J Pharmacol Exp Ther 272 1 (1995) 352-356
23. Hawk T., and Leary S. Formulary for laboratory animals (1999), Iowa State University, Iowa
24. Hawkey C.J. COX-2 inhibitors. Lancet 353 9149 (1999) 307-314
25. Hiltunen A., Aro H.T., and Vuorio E. Regulation of extracellular matrix genes during fracture healing in mice. Clin Orthop 297 (1993) 23-27
26. Hiltunen A., Metsaranta M., Perala M., et al. Expression of type VI, IX and XI collagen genes and alternative splicing of type II collagen transcripts in fracture callus tissue in mice. FEBS Lett 364 2 (1995) 171-174
27. Hiltunen A., Metsaranta M., Virolainen P., et al. Retarded chondrogenesis in transgenic mice with a type II collagen defect results in fracture healing abnormalities. Dev Dyn 200 4 (1994) 340-349
28. Hiltunen A., Vuorio E., and Aro H.T. A standardized experimental fracture in the mouse tibia. J Orthop Res 11 2 (1993) 305-312
29. Ho M.L., Chang J.K., and Wang G.J. Anti-inflammatory drug effects on bone repair and remodelling in rabbits. Clin Orthop 313 (1995) 270-278
30. Ho M.L., Chang J.K., and Wang G.J. Effects of ketorolac on bone repair: a radiographic study in modeled demineralized bone matrix grafted rabbits. Pharmacology 57 3 (1998) 148-159
31. Hogevold H.E., Grogaard B., and Reikeras O. Effects of short-term treatment with corticosteroids and indomethacin on bone healing. A mechanical study of osteotomies in rats. Acta Orthop Scand 63 6 (1992) 607-611
32. Huo M.H., Troiano N.W., Pelker R.R., et al. The influence of ibuprofen on fracture repair: biomechanical, biochemical, histologic, and histomorphometric parameters in rats. J Orthop Res 9 3 (1991) 383-390
33. Keller J., Bunger C., Andreassen T.T., et al. Bone repair inhibited by indomethacin. Effects on bone metabolism and strength of rabbit osteotomies. Acta Orthop Scand 58 4 (1987) 379-383
34. Keller J., Kjaersgaard-Andersen P., Bayer-Kristensen I., and Melsen F. Indomethacin and bone trauma. Effects on remodelling of rabbit bone. Acta Orthop Scand 61 1 (1990) 66-69
35. Khan M.I. Fracture healing: role of NSAIDs. Am J Orthop 26 6 (1997) 413
36. Le A.X., Miclau T., Hu D., and Helms J.A. Molecular aspects of healing in stabilized and non-stabilized fractures. J Orthop Res 19 1 (2001) 78-84
37. Masferrer J.L., Zweifel B.S., Seibert K., and Needleman P. Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. J Clin Invest 86 4 (1990) 1375-1379
38. Mbugua S.W., Skoglund L.A., and Lokken P. Effects of phenylbutazone and indomethacin on the post-operative course following experimental orthopaedic surgery in dogs. Acta Vet Scand 30 1 (1989) 27-35
39. Merck, Vioxx (rofecoxib) tablets. U.S. Food and Drug Administration, editor; 1999.
40. More R.C., Kody M.H., Kabo J.M., et al. The effects of two non-steroidal anti-inflammatory drugs on limb swelling, joint stiffness, and bone torsional strength following fracture in a rabbit model. Clin Orthop 247 (1989) 306-312
41. Mroszczak E.J., Jung D., Yee J., et al. Ketorolac tromethamine pharmacokinetics and metabolism after intravenous, intramuscular, and oral administration in humans and animals. Pharmacotherapy 10 6 (1990) 33S-39S
42. Mroszczak E.J., Lee F.W., Combs D., et al. Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans. Drug Metab Dispos 15 5 (1987) 618-626
43. Nelson B., Place H., Callahan B., et al. In: North American Spine Society (Ed). The effect of ketorolac on bone healing in a rabbit model (1997), Rosemont, IL 2
44. Obeid G., Zhang X., and Wang X. Effect of ibuprofen on the healing and remodelling of bone and articular cartilage in the rabbit temporomandibular joint. J Oral Maxillofac Surg 50 8 (1992) 843-849 (discussion 849-850)
45. Ratcliffe A., Doherty M., Maini R.N., and Hardingham T.E. Increased concentrations of proteoglycan components in the synovial fluids of patients with acute but not chronic joint disease. Ann Rheum Dis 47 10 (1988) 826-832
46. Ro J., Langeland N., and Sander J. Effect of indomethacin on collagen metabolism of rat fracture callus in vitro. Acta Orthop Scand 49 4 (1978) 323-328
47. Sano H., Hla T., Maier J.A., et al. In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. J Clin Invest 89 1 (1992) 97-108
48. Setton L.A., Zhu W., Weidenbaum M., et al. Compressive properties of the cartilaginous end-plate of the baboon lumbar spine. J Orthop Res 11 2 (1993) 228-239
49. Simon A.M., Manigrasso M.B., and O'Connor J.P. Cyclooxygenase-2 function is essential for bone fracture healing. J Bone Miner Res 17 6 (2002) 963-976
50. Simon AM, Sabatino CT, O'Connor JP. Effects of cyclooxygenase-2 inhibitors on fracture healing. Proceedings of the 47th annual meeting, orthopaedic research society. San Francisco, CA; 2001.
51. Sudmann E., Dregelid E., Bessesen A., and Morland J. Inhibition of fracture healing by indomethacin in rats. Eur J Clin Invest 9 5 (1979) 333-339
52. Sudmann E., and Hagen T. Indomethacin-induced delayed fracture healing. Arch Orthop Unfallchir 85 2 (1976) 151-154
53. Taylor G., and Fyfe I. The effect of ibuprofen on fracture healing. J Bone Joint Surg 70-B (1988) 850
54. Thompson Z., Miclau T., Hu D., and Helms J. A model for intramembranous ossification during fracture healing. J Orthop Res 20 (2002) 1091-1098
55. Tornkvist H., and Lindholm T.S. Effect of ibuprofen on mass and composition of fracture callus and bone. An experimental study on adult rat. Scand J Rheumatol 9 3 (1980) 167-171
56. Tornkvist H., Lindholm T.S., Netz P., et al. Effect of ibuprofen and indomethacin on bone metabolism reflected in bone strength. Clin Orthop 187 187 (1984) 255-259
57. Uusitalo H., Hiltunen A., Soderstrom M., et al. Expression of cathepsins B, H, K, L, and S and matrix metalloproteinases 9 and 13 during chondrocyte hypertrophy and endochondral ossification in mouse fracture callus. Calcif Tissue Int 67 5 (2000) 382-390
58. Vu T.H., Shipley J.M., Bergers G., et al. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93 (1998) 411-422
59. Woessner J.B. The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch Biochem Biophys 93 (1961) 440-447
60. Yu Y.M., Becvar R., Yamada Y., and Reddi A.H. Changes in the gene expression of collagens, fibronectin, integrin and proteoglycans during matrix-induced bone morphogenesis. Biochem Biophys Res Commun 177 1 (1991) 427-432